du Dr Schaeffner

Cardiovascular diseases and cancer are the leading causes of death worldwide. The co-occurrence of both is common and defines a high-risk patient cohort with high adverse outcome rates. Several issues related to cardio-oncology have been addressed by studies published in 2023 in the National Societies of Cardiology (NSC) journals.

Female participation in academic life has increased progressively in the last five decades, but gender discrepancy is still a concern in the advancement of academic careers.1 In Europe, women represent nearly half of the graduates and more than 40% of the academic staff, but only 26.2% of them reach higher ranks.2 The European Society of Cardiology (ESC) initiated sex-and-gender-related policies in 2021 to emphasize the inadequacy of women’s representation in its constituent bodies including...

Transcatheter valvular interventions (TVIs) have emerged in the wake of the successes achieved with the mitral percutaneous dilatation by Inoue, 40 years ago, and the transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis by Cribier, two decades ago. Transcatheter valvular interventions now apply with an increasing rate to several other diseases involving aortic, mitral, pulmonary, and tricuspid valves.